Piper Sandler analyst Do Kim maintains Gilead Sciences (NASDAQ:GILD) with a Neutral and raises the price target from $72 to $73.
Piper Sandler Maintains Neutral on Gilead Sciences, Raises Price Target to $73
Piper Sandler analyst Do Kim maintains Gilead Sciences (NASDAQ:GILD) with a Neutral and raises the price target from $72 to $73.